Pages that link to "Q43725536"
Jump to navigation
Jump to search
The following pages link to Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. (Q43725536):
Displaying 15 items.
- Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy (Q35605523) (← links)
- Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans (Q35646703) (← links)
- Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients (Q36043833) (← links)
- Molecular, biophysical, and pharmacological properties of calcium-activated chloride channels. (Q39102527) (← links)
- Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort (Q40204742) (← links)
- Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer (Q41161352) (← links)
- A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer? (Q42121422) (← links)
- Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. (Q48182109) (← links)
- Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas. (Q53578113) (← links)
- Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas. (Q53724691) (← links)
- Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas (Q58799507) (← links)
- ANO7 is associated with aggressive prostate cancer (Q62583662) (← links)
- Known structures and unknown mechanisms of TMEM16 scramblases and channels. (Q64938265) (← links)
- Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review (Q68739247) (← links)
- Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas (Q91560750) (← links)